DE60136430D1 - Heterosubstituierte c7-taxanacetate als antitumormittel - Google Patents

Heterosubstituierte c7-taxanacetate als antitumormittel

Info

Publication number
DE60136430D1
DE60136430D1 DE60136430T DE60136430T DE60136430D1 DE 60136430 D1 DE60136430 D1 DE 60136430D1 DE 60136430 T DE60136430 T DE 60136430T DE 60136430 T DE60136430 T DE 60136430T DE 60136430 D1 DE60136430 D1 DE 60136430D1
Authority
DE
Germany
Prior art keywords
heterosubstituted
taxanacetate
antitum
texanes
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60136430T
Other languages
German (de)
English (en)
Inventor
Robert A Holton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University Research Foundation Inc
Original Assignee
Florida State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University Research Foundation Inc filed Critical Florida State University Research Foundation Inc
Application granted granted Critical
Publication of DE60136430D1 publication Critical patent/DE60136430D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
DE60136430T 2000-02-02 2001-02-02 Heterosubstituierte c7-taxanacetate als antitumormittel Expired - Fee Related DE60136430D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17967200P 2000-02-02 2000-02-02
PCT/US2001/003600 WO2001057029A1 (en) 2000-02-02 2001-02-02 C7 heterosubstituted acetate taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
DE60136430D1 true DE60136430D1 (de) 2008-12-18

Family

ID=22657505

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136430T Expired - Fee Related DE60136430D1 (de) 2000-02-02 2001-02-02 Heterosubstituierte c7-taxanacetate als antitumormittel

Country Status (20)

Country Link
US (3) US6673833B2 (enExample)
EP (1) EP1200424B1 (enExample)
JP (1) JP2003522169A (enExample)
KR (1) KR20010112393A (enExample)
CN (1) CN1362957A (enExample)
AT (1) ATE413397T1 (enExample)
AU (1) AU776765B2 (enExample)
BR (1) BR0104353A (enExample)
CA (1) CA2368534A1 (enExample)
CZ (1) CZ20013519A3 (enExample)
DE (1) DE60136430D1 (enExample)
HK (1) HK1047935A1 (enExample)
HU (1) HUP0200651A3 (enExample)
IL (1) IL145642A0 (enExample)
MX (1) MXPA01009922A (enExample)
NO (1) NO20014758L (enExample)
NZ (1) NZ514411A (enExample)
PL (1) PL350328A1 (enExample)
WO (1) WO2001057029A1 (enExample)
ZA (1) ZA200108063B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003522169A (ja) * 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのc7ヘテロ置換アセテートタキサン
US20040210289A1 (en) * 2002-03-04 2004-10-21 Xingwu Wang Novel nanomagnetic particles
EP1534674A4 (en) 2002-08-02 2007-11-28 Immunogen Inc CYTOTOXIC AGENTS CONTAINING NEW, EFFECTIVE TAXANES AND THEIR THERAPEUTIC USE
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
US20070149496A1 (en) * 2003-10-31 2007-06-28 Jack Tuszynski Water-soluble compound
CN1960721A (zh) * 2004-03-05 2007-05-09 佛罗里达州立大学研究基金有限公司 C7乳酰氧基取代的紫杉烷类
US20050249667A1 (en) * 2004-03-24 2005-11-10 Tuszynski Jack A Process for treating a biological organism
CN1712399B (zh) * 2004-06-24 2010-08-11 中国医学科学院药物研究所 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
WO2011147330A1 (zh) 2010-05-27 2011-12-01 中国医学科学院药物研究所 双功能共缀物的化学合成及抗肿瘤与抗肿瘤转移作用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879929A (en) * 1988-06-06 1989-11-14 Roth Alfred C Tapper/threader assembly
US4950790A (en) * 1988-11-14 1990-08-21 Air Products And Chemicals, Inc. Volatile fluorinated β-ketoimines and associated metal complexes
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5243253A (en) * 1991-07-30 1993-09-07 Thomson Consumer Electronics, Inc. Color picture tube having shadow mask with improved tie bar grading
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5350866A (en) 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
ES2230790T3 (es) 1992-01-15 2005-05-01 E.R. SQUIBB & SONS, INC. Procedimientos enzimaticos para la resolucion de mezclas enantiomericas de compuestos utiles como intermedios en la preparacion de taxanos.
DE4302686C2 (de) 1992-02-05 1994-12-15 Bierther Hans Dietmar Hochleistungsventil
FR2687150B1 (fr) 1992-02-07 1995-04-28 Rhone Poulenc Rorer Sa Procede de preparation de derives du taxane.
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5939561A (en) 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
US5200534A (en) 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
DK1227093T3 (da) * 1993-03-22 2005-08-29 Univ Florida State Beta-lactamer, der kan anvendes til fremstilling af taxaner med en furyl- eller thienylsubstitueret sidekæde
US5350253A (en) * 1993-03-24 1994-09-27 John Cunningham Method for supporting distribution means
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
WO1996013495A1 (en) * 1994-10-28 1996-05-09 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
US5767297A (en) * 1997-02-05 1998-06-16 Ensuiko Sugar Refining Co., Ltd. Taxoid derivative and method of producing thereof
JP3786462B2 (ja) * 1996-03-07 2006-06-14 塩水港精糖株式会社 タキソイドの配糖化誘導体およびその製造方法
IL126856A0 (en) 1996-05-06 1999-09-22 Univ Florida State 1-Deoxy baccatin iii 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5780683A (en) * 1996-09-11 1998-07-14 Abb Lummus Global Inc. Cyclohexane oxidation
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
HU224589B1 (hu) 1997-06-03 2005-11-28 Ensuiko Sugar Refining Co., Ltd. Taxoidszármazékok és eljárás előállításukra
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
US6136988A (en) 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same
JP2003522169A (ja) * 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのc7ヘテロ置換アセテートタキサン
EP1175414A1 (en) 2000-02-02 2002-01-30 Florida State University Research Foundation, Inc. Taxane formulations having improved solubility

Also Published As

Publication number Publication date
MXPA01009922A (es) 2003-07-14
KR20010112393A (ko) 2001-12-20
WO2001057029A1 (en) 2001-08-09
CN1362957A (zh) 2002-08-07
PL350328A1 (en) 2002-12-02
EP1200424B1 (en) 2008-11-05
AU776765B2 (en) 2004-09-23
US6673833B2 (en) 2004-01-06
HUP0200651A3 (en) 2002-10-28
EP1200424A1 (en) 2002-05-02
NO20014758L (no) 2001-11-29
BR0104353A (pt) 2002-04-16
ZA200108063B (en) 2003-12-01
HK1047935A1 (zh) 2003-03-14
US20050143446A1 (en) 2005-06-30
US20020065305A1 (en) 2002-05-30
NO20014758D0 (no) 2001-10-01
US7183312B2 (en) 2007-02-27
IL145642A0 (en) 2002-06-30
ATE413397T1 (de) 2008-11-15
JP2003522169A (ja) 2003-07-22
CA2368534A1 (en) 2001-08-09
HUP0200651A2 (hu) 2002-07-29
US6861446B2 (en) 2005-03-01
AU3480401A (en) 2001-08-14
NZ514411A (en) 2005-02-25
CZ20013519A3 (cs) 2002-04-17
US20040087547A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
ATE381328T1 (de) Heterosubstituierte taxan-c10-acetate als antitumormittel
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
MY137637A (en) C7 ester substituted taxanes
AU1676200A (en) Polyhydroxylated heterocyclic derivatives as anti-coagulants
PT1109812E (pt) Pirrolobenzodiazepinas
ATE403429T1 (de) Spiropyrazol-verbindungen
ATE413397T1 (de) Heterosubstituierte c7-taxanacetate als antitumormittel
BG105964A (en) C(10) carbonate substituted taxanes and their use as antitumor agents
DE60134814D1 (de) C10-carbamoyloxysubstituierte taxane als antitumormittel
DE60138853D1 (de) C10-taxanester als antitumormittel
BG105966A (en) C7 carbonate substituted taxanes and their application as antitumor agents
DE60133600D1 (de) C7-carbamoyloxysubstituierte taxane als antitumormittel
ATE282611T1 (de) Stolonoxide
SG125888A1 (en) C10 carbonate substituted taxanes
MXPA01007972A (es) Esteres de taxanos c10 sustituidos.
SG125889A1 (en) C7 ester subsituted taxanes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee